The steroid hormone 1,25-dihydroxyvitamin D 3 [1, 25(OH) 
D 3 ] and 24,25-dihydroxyvitamin D 3 [24,25(OH) 2 D 3 ]. 1,25(OH) 2 D 3 is well known for its hormonal activity in diverse cell types, and its ability to enhance intestinal calcium and phosphate absorption. By comparison 24,25(OH) 2 D 3 has not been as widely studied. However, a growing body of literature has indicated that 24,25(OH) 2 D 3 has important effects in development of bone mass. Somjen et al. [1983] reported that 24R, 25(OH) 2 D 3 but not 24S, 25(OH) 2 D 3 was active in bone while Ono et al. [1996] reported 24, 25(OH) 2 D 3 is found in fracture calluses in bone [Henry and Norman, 1978; Somjen et al., 1983; Ono et al., 1996] .
One goal in poultry production is to increase the amount of meat on animals, which in turn requires sufficient support of bone structure. To date, strategies for improving bone strength have included increasing dietary calcium and phosphate, as well as vitamin D. Knowing the effects of 24,25(OH) 2 D 3 on phosphate and calcium absorption in vivo has great significance to approaching this goal. Previous work in our lab [Nemere, 1996a] indicated that 24R,25(OH) 2 D 3 inhibits the rapid stimulation of calcium and phosphate transport mediated by 1,25(OH) 2 D 3 in isolated chick intestinal cells and perfused duodenal loops. In addition Toffolon et al. [1975] found that 24,25(OH) 2 D 3 decreased calcium absorption in dogs and Maeda et al. [1987] reported that it caused hypocalcemia in rats. However the effects of 24,25(OH) 2 D 3 on phosphate transport in vivo remain unknown [Akiko et al., 1997] .
The current study was undertaken to determine whether 24R, 25(OH) 2 D 3 or 24S, 25(OH) 2 D 3 alters phosphate transport in the whole animal and if there is any confounding factor present in vivo.
After establishing a time for linear transport in vivo, the experiments are designed in four parts. #1 Chicks were raised on regular diet with variable times of fasting before experiments.
They were then injected with 24R,25(OH) 2 D 3 or 24S,25(OH) 2 D 3 at different time points (1, 5, 10, 15 , and 18 h) before experimentation and effects on phosphate transport analyzed.
#2 Chicks were raised on regular diet with a constant period of fasting before experimentation and they were then injected with 24R,25(OH) 2 D 3 or 24S,25(OH) 2 D 3 at different time points (1, 5, 10, 15 , and 18 h) before experimentation and then the effects of the metabolites tested on phosphate transport. #3 Chicks were raised on a low vitamin D diet without a constant 18 h of fasting before experiments. They were then injected with 24R, 25(OH) 2 D 3 or 24S, 25(OH) 2 D 3 at different time points (1, 5, 10, 15 , and 18 h) before experimentation and then the effects of the metabolites tested on phosphate transport. #4 After determining the optional time for observing steroid affects on phosphate transport, does-response studies were undertaken. Range finding were accomplished with does of 100, 200, and 300 µg 24R,25(OH) 2 D 3 .
CHAPTER II LITERATURE REVIEW

Background
Vitamin D was discovered because of a disease named rickets in young animals; in adults this condition is known as osteomalacia. Professor Francis was the first to describe vitamin D deficiency as rickets in 1650. Rickets is now known as softening and weakening of the bone which results in leg bones bowing under the weight of children's upper torsos. This disease became the key to discovering vitamin D, which was considered a new nutritional factor [Hess, 1922; Mohr et al., 2008] . It was not initially Table 1 below for summary of metabolites). They play an important role in calcium and phosphate homeostasis in the body. 1,25(OH) 2 D 3 is the most well studied metabolite of vitamin D. A major function of 1,25(OH) 2 D 3 is to enhance serum calcium and phosphate concentrations [Bachelet et al., 1979] . This is accomplished by its action on three organ systems.
The first is intestine where it acts to enhance the dietary absorption of calcium and phosphate [Corradino and Wasserman, 1968] . Second, in the kidney, it stimulates reabsorption . Third is in the bone to enhance the resorption and storage of these two minerals. The production and degradation of 1,25(OH) 2 D 3 are processes regulated by feedback mechanisms resulting from ionic (Ca 2+ , PO 4 -), polypeptide hormones (PTH, calcitonin, , and steroid factors [Bourdeau et al., 1990; Rohe et al., 2007; Khanal and Nemere, 2008] . Nemere [1996b] has found that modulation of calcium and phosphate transport in the epithelia by 1,25(OH) 2 D 3 acts both through genomic and membrane-initiated actions. While the genomic regulation of phosphate homeostasis is mediated through the well-known vitamin D receptor (VDR) system; pre-genomic regulation involves the 1,25D 3 -MARRS receptor also identified as ERp57 and PDIA3 [Larsson and Nemere, 2003; Tunsophon and Nemere, 2010] . In part, the nuclear action of 1,25(OH) 2 D 3 functions through the classical vitamin D receptor (VDR). VDR is a member of the nuclear receptor family of transcription factors. [Nemere et al., 1994] . This separate membrane receptor was isolated from chick intestinal basal lateral membranes and was functionally linked to the rapid uptake of phosphate in intestinal cells by using ribozyme knockdown [Nemere et al., 2004.] [Nemere and Norman, 1988] . Steroid hormone stimulated rapid uptake and transport of calcium and phosphate is mediated by the 1,25D 3 -MARRS protein. Receptor-ligand binding then activates the PKC pathway to stimulate phosphate uptake while the PKA pathway mediates calcium uptake [Nemere, 1996c; Rohe et al., 2005] .
Functions attributed to 1,25(OH) 2 D 3 other than mineral ion homeostasis include regulation of gene transcription, promotion of cell proliferation, and stimulation of the immune system [Khanal and Nemere, 2009; Richard et al., 2010; Wu et al., 2010] . Olson and Deluca [1969] reported that 25(OH)D 3 could increase calcium uptake in rat and chick duodena. Also Nemere [1996c] found that in perfused duodenal loops the mono-hydroxylated metabolite failed to stimulate phosphate transport at normal circulating levels and also abolished the stimulatory response to 1, 25(OH) [Yukihiro et al., 1994; Khoury et al., 1995; Takeuchi and Guggino, 1996] and PKC activation in chick enterocytes [Nemere, 1999] . 24,25 ( [Yoshimoto and Norman, 1986] . One mechanism of inhibition was then found to be oxidation of the 1,25D 3 -MARRS receptor and inhibition of 1,25(OH) 2 D 3 binding . Antioxidant diets nearly doubled phosphate absorption in vivo . Peery and Nemere [2007] then proved the hypothesis that anti-oxidant conditions, such as an anti-catalase antibody or excess exogenous catalase protein, could block the inhibitory action of 24,25(OH) 2 D 3 , whereas pro-oxidant conditions, such as a triazole inhibitor of catalase activity, could mimic the inhibitory action of the secosteroid. It was further recognized that H 2 O 2 could also influence the signal transduction pathway beyond ligand binding to the 1, 25(OH) 2 D 3 -MARRS receptor [Peery and Nemere, 2007] .
The model for the interaction between the 1,25D 3 -MARRS receptor and catalase is described in Fig. 2 [Tatsuo, 2004; Adams and Hewison, 2010] . The reason why vitamin D deficiency can result in lower bone mineral density and an increased risk of bone loss (osteoporosis) or bone fracture is because a lack of vitamin D alters mineral metabolism in the body [Lips, 2010] . This suggests that phosphate plays a very important role in bone health either in bone formation and bone mineral density.
Phosphates are normally absorbed from food and are important chemicals in the body. They are involved in cell structure, energy transport and storage, vitamin function, and numerous other processes essential to health [Holick, 2005] . White et al. [2011] tested the effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement (GHR) in adult growth hormone deficiency [Marry et al., 1976] . Phosphate and alendronate therapy given in combination with GHR confer an advantage in terms of bone mineral density (BMD) increase.
Phosphate appears to exert its effect by increasing PTH target-organ action, whereas alendronate acts primarily through reduction in bone resorption [Nemere, 2007] . It was also recently reported that phosphorus has a unique role in bone formation and osteocyte maturation recently. In addition phosphate levels in blood are also very important to heart and kidney disease. determined that 5 min transport period was within a linear range. After 5 min of transport, blood was collected by decapitation before preparation of serum, and radioactivity determined by liquid scintillation spectrophotometry.
In one set of experiments chicks were anesthetized with ether. Although no significant differences were eventually found between results with ether or chloropent anesthesia, ether was not used because of potential oxidant formation.
Time courses studies
The chicks were divided into three groups in each time course study. 
Statistical analyses
Statistical comparisons between treatment groups were made using ANOVA. propanediol) at selected hours before experimentation, and at the same time the chicks (n=12) of the treated groups (with hormone) were injected with 24R,25(OH) 2 D 3 in vehicle. Before experimentation, chicks were only fed water. After the selected hours, all chicks were anesthetized prior to surgical exposure of the duodenal loop and injection of a solution containing H 3 32 PO 4 into the lumen. According to the initial time course study, Fig. 3 . Time course study of 32 P transport in chick intestine. 18 chicks were divided into four groups. They were anesthetized with 0.3 ml chloropent /100g of body weight. The abdominal cavity was surgically opened and the duodenal loop injected with 1 ml GBSS containing 1µCi of 32 P. After waiting for (1) T=3 min (n=6); (2) T=6 min (n=6); (3) T=9 min (n=6); (4) T=12 min (n=3), blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours to allow clot formation and radioactivity determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. after 5min of transport, serum levels of radioactivity were used to determined phosphate absorption.The results show 1 h and 5 h after injection of 24R,25(OH) 2 D 3 there was no difference in phosphate absorption between the control and treated groups. A slight inhibition was found at the10-hour time point; and a dramatic response was obtained at 15 and 18 h (Fig. 4) . Time course of 24R,25(OH) 2 D 3 effect on 32 P transport in chick intestines with variable times of fasting. Chicks were divided into five groups, 24 in each group and each group further divided into two groups, control (C, n=12) and treated (D, n=12). They were raised on a regular diet (800 IU vitamin D /kg) generally for 3 weeks prior to experimentation. On the day of use, chicks in control groups were injected with vehicle at the indicated hours before experimentation and at the same time the chicks of the treated groups injected with 24R,25(OH) 2 D 3 in vehicle. After selected hours (1, 5, 10, 15 , and 18h) of fasting, they were anesthetized with a 0.3 ml chloropent /100g of body weight. The abdominal cavity was surgically opened and the duodenal loop injected with1 ml GBSS containing 1µCi of 32 P. After 5min, blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours to allow clot formation and radioactivity determined by liquid scintillation spectrophotometry. were observed between control and treated groups at any of the time points (P>0.2). Also, in this figure, it is evident that there was a large range in phosphate absorption from 1 h to 15 h, which further indicates that diet is one of the confounding factors in phosphate transport. General nutrient uptake may affect gastrointestinal hormones (GI hormone), which may increase the phosphate uptake. The increase in phosphate absorption in controls at the later time points may be due to an increase in transporters at the brush border surface. Fig. 5 . Time course of 24S,25(OH) 2 D 3 effect on 32 P transport in chick intestines with variable times of fasting. Chicks were divided into two groups, control and treated, 60 in each group and each group further divided into four time groups, 1h (n=3), 5 (n=3), 10 (n=30), 15 (n=30). They were raised on a regular diet (800 IU vitamin D /kg) generally for 3 weeks prior to experimentation. On the day of use, chicks in control groups were injected with vehicle at the indicated times before experimentation, and at the same times the chicks of the treated groups were injected with 24S,25(OH) 2 D 3 in vehicle. After selected hours (1, 5, 10 , and 15 h) of fasting, they were anesthetized with 0.3 ml chloropent /100g of body weight. The abdominal cavity was surgically opened and the duodenal loop injected with1 ml GBSS containing 1µCi 32 P. After 5 min, blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours to allow clot formation and radioactivity determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. C, vehicle control; D, 20µg 24S,25(OH) 2 D 3 . 
Phosphate absorption after constant 18 h fasting in chicks on a normal vitamin D diet
Clearly the variable times of fasting had an impact on phosphate absorption (Figs. 4, 5). To exclude this confounding factor shown in Fig. 4 and Fig. 5 , chicks in the next series of experiments were raised on regular diet for three weeks but prior to use, they were all fasted for 18 h before experimentation. In these studies, chicks were injected with 24R,25(OH) 2 D 3 or vehicle. Fig. 6 . Time course of 24R,25(OH) 2 D 3 effect on 32 P transport in chick intestines with a constant 18 hours of fasting. Chicks were divided into six groups, control (n=17), 1h (n=7), 5 h (n=10), 10h (n=9), 15h (n=13) and 18h (n=15). They were raised on a regular diet (800 IU vitamin D /kg) for 3 weeks prior to experimentation. On the day of use, chicks in control groups were injected with vehicle 18 hours before experimentation at the same time the chicks of the treated groups began fasting and were served only water. At the indicated hours before experimentations chicks of the treated groups were injected with 24R,25(OH) 2 D 3 in vehicle. After selected hours (1, 5, 10, 15 and 18 h) they were anesthetized with 0.3 ml /100g of body weight chloropent. The abdominal cavity was surgically opened and injected with1 ml GBSS containing 1µCi 32 P in the duodenal loop. After 5 min of absorption, blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours and radioactivity determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. *P<0.05, relative to vehicle controls. Figs. 4 and 5, the range of 32 P absorption is considerably less than that depicted in Fig. 6 . In addition, the 1 h and 5 h steroid treated groups also showed a significant decrease (P<0.02) in phosphate transport relative to controls, instead of only at 15 h and 18 h. At 10 h 24R,25(OH) 2 D 3 again failed to inhibit phosphate transport even after 18 h of constant fasting before experimentation. As seen previously (Fig. 4) , however, 24R,25(OH) 2 D 3 inhibited phosphate absorption at the 15-and 18-h time points (Fig. 6) . Fig. 7 . Time course of 24S,25(OH) 2 D 3 effect on 32 P transport in chick intestines with constant 18 hours of fasting. Chicks were divided into six groups, control (n=12), 1 h (n=9), 5 h (n=10), 10 h (n=8), 15 h (n=8) and 18 h (n=8). They were raised on a regular diet (800 IU vitamin D /kg) for 3 weeks prior to experimentation. On the day of use, chicks in control groups were injected with vehicle 18 h before experimentation and at the same time the chicks of the treated groups began fasting and were only fed on water. At selected hours before experimentation chicks of the treated groups were injected with 24S,25(OH) 2 D 3 in vehicle. After selected hours (1, 5, 10, 15 , and 18 h) they were anesthetized with 0.3 ml chloropent /100g of body weight. The abdominal cavity was surgically opened and the duodenal lumen injected 1 ml GBSS containing 1µCi 32 P. After 5min of absorption, blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours and radioactivity determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. secretion [Nemere, 1996b] which further stimulates phosphate absorption. Fig. 8 . Dose-response study of 24R,25(OH) 2 D 3 effect on 32 P transport in chick intestines with a constant 18 hours of fasting. Chicks were raised on a regular diet (800 IU vitamin D /kg) for 3 weeks prior to experimentation. Chicks were divided into four groups, control (n=5), 100 µg (n=3), 200 µg (n=3) and 300 µg (n=). They were injected with vehicle (1:1 ethanol: propanediol), 100 µg 24R,25(OH) 2 D 3 in vehicle, 200 µg 24R,25(OH) 2 D 3 in vehicle or 300 µg 24R,25(OH) 2 D 3 in vehicle, respectively, 1 h before experimentation. On the experimentation they were anesthetized with 0.3 ml chloropent /100g of body weight. The abdominal cavity was surgically opened and injected with1 ml GBSS containing 1µCi 32 P in the duodenal loop. After 5min of absorption, blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours and radioactivity determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. *P<0.05, relative to vehicle controls.
Compared with
Phosphate absorption with chicks on a low vitamin D diet, no fasting To further exclude the diet's effect on phosphate absorption, chicks in this series of experiments were raised on a low vitamin D diet for 3 weeks before the experiments with no fasting before experimentation. Previous experiments showed 24R,25(OH) 2 D 3 has a hypophosphatemic effect in vivo after 1, 5, 15 , and 18 h following injection with 18 h constant fasting before experimentation. Figure 9 shows the results of absorption in chicks raised on a low vitamin D diet, and ANOVA confirmed that the 1-h, 5-h, 10-h, and 15-h groups all exhibited a decreased phosphate absorption compared with control groups (P<0.02). In the 1-h group, phosphate absorption decreased by 50% compared with the chicks that were raised on regular diet in which phosphate transport decreased by 30%.
However the latter decrease was not significantly different than control, which indicates that the vitamin D level in the diet is one of the confounding factors that may affect phosphate transport in vivo. Fig. 9 . Time course of 24R,25(OH) 2 D 3 effect on 32 P transport in chick intestines in chicks raised on a low vitamin D diet but not fasted. Chicks were divided into six groups, control (n=12), 1 h (n=6), 5 h (n=9), 10 h (n=9), 15 h (n=10) and 18 h (n=8). They were raised on a low vitamin D diet (200 IU vitamin D /kg) for 3 weeks prior to experimentation. On the day of use, chicks of control groups were injected with vehicle 18 h before experimentation. At selected hours (1, 5, 10, 15 , and 18 h) before experimentation chicks of the treated groups were injected with 24R,25(OH) 2 D 3 in vehicle. On the day of experimentation they were anesthetized with 0.3 ml chloropent /100g of body weight. The abdominal cavity was surgically opened and injected with 1 ml GBSS containing 1µCi 32 P into the lumen of duodenal loop. After 5min, blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours and radioactivity determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. * P<0.05, relative to vehicle controls. the phosphate transport at the 5-h time point after injection (P<0.05), but no significant differences were observed at the other time points. Fig. 10 . Time course of 24S,25(OH) 2 D 3 effect on 32 P transport in chicks raised on a low vitamin D diet but not fasted. Chicks were divided into six groups, control (n=9), 1 h (n=9), 5 h (n=9), 10 h (n=8), 15 h (n=9) and 18 h (n=10). They were raised on a low vitamin D diet (200 IU vitamin D /kg) generally for 3 weeks prior to experimentation. On the day of use, chicks of control groups were injected with vehicle 18 h before experimentation. And the treated groups were injected with 24S,25(OH) 2 D 3 in vehicle1, 5, 10, 15, and 18 h before experimentation. After selected hours (1, 5, 10, 15 , and 18 h), they were anesthetized with a 0.3 ml chloropent /100g of body weight. The abdominal cavity was surgically opened and injected with 1 ml GBSS containing 1µCi of 32 P into the lumen of duodenal loop. After 5 min, blood was collected by decapitation. Serum from the samples was obtained after storage at 4 C for several hours and radioactivity determined by liquid scintillation spectrophotometry. Data are presented as mean + SEM. * P<0.05, relative to vehicle controls. In previous reports, the enzyme catalase was proved to be a cellular binding protein for 24,25(OH) 2 D 3 [Larsson et al., 2006] . Catalase activity could be inhibited by 24,25(OH) 2 D 3 and production of H 2 O 2 increased in intestinal cells .
Hydrogen peroxide, in turn, oxidizes thiols within the 1,25D 3 -MARRS receptor to decrease binding of 1,25(OH) 2 D 3 , and also inhibit the rapid stimulation of the protein kinase C signaling pathway [Peery and Nemere, 2007] .
In the present study, it was found that the two isomers of 24, [Nemere, 1996b] . There might be a separate nuclear receptor for 24,25(OH) 2 D 3 which could induce genomic change in cells resulting in a decreased absorption of phosphate after 1 h.
Another mechanism maybe catalase binding to STAT3 [Ndubuisi et al., 1999] [Nemere and Szego, 1981a; Nemere and Szego, 1981b] . As noted earlier, the higher cpms at longer fasting times might be due to increased phosphate transporters appearing at the brush border membrane.
This research increases our understanding of the effects of 24,25(OH) 2 D 3 on phosphate transport in vivo, and its two isomers. By understanding the action of these two isomers, progress will be made in enhancing phosphate absorption in production animals to supply the minerals for adequate bone growth. Moreover, more efficient utilization of phosphate in the diet will provide the benefits of reducing feed costs and reducing phosphorous excretion, thereby contributing to the sustainability of agriculture in the United States. Also these studies have implications for bone health in all animals, including humans to prevent rickets in children and osteoporosis in adults. 
